Definitive Healthcare Corp. Stock Price, News & Analysis

Definitive Healthcare Corp. (Nasdaq: DH) announced a public offering of 11 million shares of its Class A common stock at $36.00 per share. The offering includes a 30-day option for underwriters to purchase an additional 1.65 million shares. Closing is anticipated on November 22, 2021. Proceeds will fund acquisitions and general corporate purposes, such as buying 7 million limited liability interests from its subsidiary and repurchasing 2.23 million Class A shares. The offering is managed by Goldman Sachs & Co. and J.P. Morgan among others.

Definitive Healthcare Corp. (Nasdaq: DH) has initiated a public offering of 11,000,000 shares of its Class A common stock, with an option for underwriters to acquire an additional 1,650,000 shares. The net proceeds will fund acquisitions and general corporate purposes, including purchasing up to 7,000,000 limited liability interests from its subsidiary, AIDH TopCo, LLC, and repurchasing up to 2,233,238 shares of Class A stock. The offering is managed by leading financial firms, with a prospectus available through the SEC.

Definitive Healthcare Corp. (Nasdaq: DH) reported a strong Q3 2021, with revenue of $43.1 million, up 43% year-over-year. However, the company incurred a GAAP net loss of $(21.0) million, a significant rise from $(10.0) million in Q3 2020. Adjusted net income fell to $2.2 million compared to $5.1 million in the same quarter last year. The company forecasted Q4 2021 revenue between $44 million and $45 million, expecting a 32% year-over-year increase. Despite the losses, customer growth surged by 49%, reaching 377 clients with $100,000 or greater in annual recurring revenue.

Definitive Healthcare has integrated extensive Asian data sources into Monocl ExpertInsight, enhancing its platform with over 11 million worldwide expert profiles, focusing on the Chinese and Japanese healthcare markets. This expansion responds to customer demand for deeper insights in the APAC region, facilitating better expert identification and engagement strategies. The update includes local language capabilities, aiding medical professionals in understanding local experiences and exploring new scientific activities. This move aims to strengthen relationships and expand market presence in Asia-Pacific.

Definitive Healthcare Corp. (Nasdaq: DH) will release its third quarter financial results on November 8, 2021, after market close. A conference call is scheduled for 5:00 PM ET to discuss the results. Investors can access a live audio webcast on Definitive Healthcare’s Investor Relations website and dial in via provided numbers. The call will also be available for replay until November 22, 2021. Definitive Healthcare focuses on providing data and analytics to enhance commercial success in the healthcare sector.

Definitive Healthcare (Nasdaq: DH) has launched Latitude Reporting, a product that enables real-time custom patient cohort analysis targeting specific disease states. The tool allows life sciences companies to swiftly analyze extensive medical and prescription claims data, enhancing their go-to-market strategies. Users can create and adjust patient cohorts, gaining insights from billions of claims to support informed commercial decisions. Latitude Reporting aims to streamline healthcare data utilization, catering to various roles within the industry.

Definitive Healthcare (Nasdaq: DH) has appointed Robert Musslewhite as President, enhancing its Executive Leadership Team during a period of rapid growth. Musslewhite brings extensive healthcare experience, previously leading OptumInsight and serving on Definitive Healthcare's board. With a total addressable market exceeding $10 billion and a unique SaaS platform, the company is set for significant impact in the healthcare industry. His expertise is expected to drive the development of new commercial intelligence solutions.

Definitive Healthcare Corp. has successfully closed its initial public offering, selling 17,888,888 shares of Class A common stock at $27.00 per share. This offering includes the full exercise of the underwriters' option for an additional 2,333,333 shares, yielding approximately $483 million in gross proceeds. The stock began trading on the Nasdaq Global Select Market under the symbol DH on September 15, 2021. Major underwriters include Goldman Sachs and J.P. Morgan.

Definitive Healthcare Corp. has announced the pricing of its initial public offering (IPO) for 15,555,555 shares of Class A common stock at $27.00 per share. The offering allows underwriters a 30-day option to buy an additional 2,333,333 shares. Trading on the Nasdaq Global Select Market under ticker symbol 'DH' is set to start on September 15, 2021, with closure of the offering anticipated on September 17, 2021. Goldman Sachs and J.P. Morgan are leading the underwriting team.